Sterling Conley v. HHS - Influenza, Guillain-Barre syndrome (GBS) (2025)

On April 18, 2024, Sterling Conley filed a petition alleging that he developed Guillain-Barre syndrome after vaccinations administered on December 1, 2022. The petition referred to an influenza vaccine and Prevnar-13, but the public ruling notes that the vaccination record documented a pneumococcal 20-valent conjugate vaccine (PCV-20) rather than Prevnar-13.

Respondent filed an amended Rule 4(c) report on September 12, 2025 conceding entitlement under the Vaccine Injury Table for flu-associated GBS. Respondent agreed that Mr.

Conley satisfied the Table and QAI criteria, which presume causation when GBS begins between three and forty-two days after a seasonal influenza vaccination and there is no apparent alternative cause. Respondent did not concede that PCV-20 caused GBS.

Chief Special Master Brian H. Corcoran granted entitlement on September 15, 2025.

The public ruling does not provide the exact onset date, hospitalization, diagnostic testing, treatment, or damages evidence. Compensation remains pending.